Last year, former GSK oncology head Christine Roth took on the challenge of leading the oncology group at German pharma giant Bayer. Her task—to push the company further into the lucrative market—has ...
Oncology is hardly what Bayer is known for. But the German drugmaker has raided GlaxoSmithKline—which is itself reestablishing a cancer foothold—for a new leader in the field. Christine Roth, ...
Christine Roth, Executive Vice President and Head of Bayer’s Oncology Strategic Business Unit Bayer is counting on its growing oncology business to deliver one third of the $30 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results